ROLE OF PHYSICAL ACTIVITY IN THE MULTIDISCIPLINARY MANAGEMENT OF CYSTIC FIBROSIS: A LITERATURE REVIEW
Abstract
Introduction: Cystic fibrosis (CF) is a multisystem genetic disorder in which progressive pulmonary disease remains the leading cause of morbidity and mortality. Advances in pharmacological therapy, particularly CFTR modulators, have transformed the clinical landscape; however, non-pharmacological strategies—especially structured physical activity (PA)—remain essential for optimising long-term outcomes. This review synthesises current evidence on the physiological basis, clinical benefits, safety considerations, and practical implementation of PA as part of multidisciplinary CF management.
Methods: A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for peer-reviewed articles published between 2020 and 2025. Search terms included cystic fibrosis; physical activity; exercise training; pulmonary rehabilitation; multidisciplinary care. Randomised controlled trials, systematic reviews, meta-analyses, and relevant clinical guidelines were included.
Results: Evidence consistently shows that regular physical activity improves exercise capacity, enhances mucus clearance, and contributes to stabilizing or improving selected parameters of lung function in people with cystic fibrosis. Aerobic, endurance, combined, and inspiratory muscle training provide complementary benefits for cardiovascular fitness, muscle strength, bone health, and mental well-being. Home-based programs, supported by telemedicine, offer comparable results to in-person training while reducing the risk of infection. Regular physical activity is often hindered by disease symptoms, limited access to appropriate sports facilities, and psychosocial limitations. However, there are facilitating factors, such as personalized exercise recommendations, support from an interdisciplinary team, and digital monitoring technologies, which enable ongoing patient engagement.
Conclusions: Physical activity is a safe, effective, and versatile component of multidisciplinary CF care, offering physiological, functional, and psychosocial benefits that complement pharmacological and airway clearance therapies. Integrating tailored exercise interventions into routine management should be prioritised to maximise health outcomes and quality of life in this population.
References
Mall MA, Burgel PR, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL. Cystic fibrosis. Nat Rev Dis Primers. 2024;10(1):53. doi:10.1038/s41572-024-00538-6
Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021;397(10290):2195–2211. doi:10.1016/S0140-6736(21)00608-3
Castellani C, De Boeck K, De Wachter E, Sermet-Gaudelus I, Simmonds NJ, Southern KW; ECFS Diagnostic Network Working Group. ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria. J Cyst Fibros. 2022;21(6):908–921. doi:10.1016/j.jcf.2022.09.011
Southern KW, Addy C, Bell SC, et al. Standards for the care of people with cystic fibrosis; establishing and maintaining health. J Cyst Fibros. 2024;23(1):12–28. doi:10.1016/j.jcf.2023.12.002
Sutharsan S, Wallis CE, Miller M, et al. Real-world impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: German registry data. Lancet Reg Health Eur. 2023;27:100690. doi:10.1016/j.lanepe.2023.100690
Bower JK, Volkova N, Ahluwalia N, et al. Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results from a long-term registry-based study. J Cyst Fibros. 2023;22(4):730–737. doi:10.1016/j.jcf.2023.03.002
Uluer AZ, MacGregor G, Azevedo P, et al. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. Lancet Respir Med. 2023;11(6):550–562. doi:10.1016/S2213-2600(22)00504-5
Hoppe JE, et al. Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE trial VX21-121-105): an analysis from a single-arm, phase 3 trial. Lancet Respir Med. 2024;13:. doi:10.1016/S2213-2600(24)00407
Southern KW, Castellani C, Lammertyn E, et al. Standards of care for CFTR variant-specific therapy for people with cystic fibrosis. J Cyst Fibros. 2023;22(1):17–30. doi:10.1016/j.jcf.2022.10.002
Tümmler B, Pallenberg ST, Dittrich AM, et al. Progress of personalized medicine in cystic fibrosis in the era of efficient CFTR modulators. Mol Cell Pediatr. 2025;12(1):6. doi:10.1186/s40348-025-00194-0
Trimble A, Zeman K, Wu J, et al. Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: a randomised controlled trial. PLoS One. 2022;17(5):e0268622. doi:10.1371/journal.pone.0268622.
Warnock L, Gates A. Airway clearance techniques compared to none for cystic fibrosis. Cochrane Database Syst Rev. 2023;4:CD013610. doi:10.1002/14651858.CD013610.pub2
Stallings VA, et al. Pancreatic enzyme replacement therapy in cystic fibrosis: clinical practice and patient outcomes. J Cyst Fibros. 2024;23(1):e1-e9. doi:10.1016/j.jcf.2023.08.004.
Dawson S, Girling C-J, Cowap L, Clark-Carter D. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis. Cochrane Database Syst Rev. 2023;3:CD013766. doi:10.1002/14651858.CD013766.pub2.
Tran QT, Aliaj E, Olmsted MG, Hempstead SE, Lomas PH, Brown RF, Flume PA, et al. People with cystic fibrosis and care teams share how CF care can change to meet patient needs. J Cyst Fibros. 2024;23(6):1066–1071. doi:10.1016/j.jcf.2024.09.002.
Pessoa E, Ferreira M, Baixinho CL. Telerehabilitation in children and adolescents with cystic fibrosis: a scoping review. Healthcare (Basel). 2024;12(10):971. doi:10.3390/healthcare12100971.
Heinz KD, Walsh A, Southern KW, et al. Exercise versus airway clearance techniques for people with cystic fibrosis. Cochrane Database Syst Rev. 2022;(6):CD013285. doi:10.1002/14651858.CD013285.pub2.
Caterini JE, Op’t Veld B, Hebestreit H. Exercise intolerance in cystic fibrosis – the role of CFTR and oxygen transport pathways. Pediatr Pulmonol. 2022;57(6):1503–1512. doi:10.1002/ppul.25275.
Radtke T, Hebestreit H, Radtke T, et al. Cardiopulmonary exercise testing provides prognostic information in advanced cystic fibrosis. Am J Respir Crit Care Med. 2024;preprint.
Du Berry C, Lauzon M, Hebestreit H, et al. Associations between peak oxygen uptake, lung function and prognosis in cystic fibrosis. Pediatr Pulmonol. 2021;56(8):2624–2632. doi:10.1002/ppul.25275.
Radtke T, et al. Exercise training in cystic fibrosis: A systematic review and meta-analysis. Sports Med. 2022;52(6):1381–1403. doi:10.1007/s40279-021-01594-3
Curran M, Tierney AC, Collins L, Kennedy L, McDonnell C, Jurascheck AJ, Sheikhi A, Walsh C, Button B, Casserly B, Cahalan R. Steps Ahead: Optimising physical activity in adults with cystic fibrosis: A pilot randomised trial using wearable technology, goal setting and text message feedback. J Cyst Fibros. 2023 May;22(3):570–576. doi: 10.1016/j.jcf.2022.11.002
Elborn JS, Manderscheid D, Summer D, et al. High-intensity interval training improves exercise capacity and ventilatory efficiency in adults with cystic fibrosis: a randomized controlled trial. J Cyst Fibros. 2021;20(5):793–803. doi:10.1016/j.jcf.2021.03.002.
Kinaupenne M, De Craemer M, Schaballie H, Vandekerckhove K, Van Biervliet S, Demeyer H. Physical activity and its correlates in people with cystic fibrosis. Eur Respir Rev. 2022;31(165):220010. doi:10.1183/16000617.0010-2022.
Hebestreit H, Hulzebos EHJ, Schneiderman JE, Karila C, Boas SR, Kriemler S, et al. Partially supervised conditioning improves capacity, exercise tolerance and quality of life in cystic fibrosis: A randomized controlled trial. Pediatr Pulmonol. 2021;56(2):388–397. doi:10.1002/ppul.25183
Gruber W, Orenstein DM, Hebestreit A, Schneiderman JE, Kriemler S, Radtke T, et al. Long-term exercise training in children with cystic fibrosis: Effects on aerobic fitness and lung function. Pediatr Pulmonol. 2022;57(7). doi:10.1002/ppul.25966
Sawyer A, Cavalheri V, Jenkins S, Wood J, Cecins N, Bear N, Singh B, Gucciardi D, Hill K. High-Intensity Interval Training Is Effective at Increasing Exercise Endurance Capacity and Is Well Tolerated by Adults with Cystic Fibrosis. J Clin Med. 2020;9(10):3098. doi:10.3390/jcm9103098.
Capasso CR, Miniato AL, Di Filippo P, Di Ludovico A, Di Pillo S, Chiarelli F, Sferrazza Papa GF, Attanasi M. The Impact of Physical Activity on Clinical Outcomes in Children with Cystic Fibrosis: A Narrative Review. Children. 2025;12(3):831. doi: 10.3390/children12030831
Savi D, et al. Physical activity and glucose metabolism in cystic fibrosis. J Cyst Fibros. 2021;20(5):789–792. doi:10.1016/j.jcf.2021.04.007
Giannakoulakos S, Gioulvanidou M, Kouidi E, Peftoulidou P, Kyrvasili SS, Savvidou P, Deligiannis A, Tsanakas J, Hatziagorou E. Physical Activity and Quality of Life among Patients with Cystic Fibrosis. Children. 2022;9(11):1665. doi: 10.3390/children9111665
Hebestreit H, Kriemler S, Schneiderman JE, Hulzebos EHJ, van de Weert-van Leeuwen PBW, et al. Physical activity interventions ≥ 6 months probably improve VO₂peak in individuals with cystic fibrosis: a Cochrane systematic review. Cochrane Database Syst Rev. 2022;(8):CD002768. doi:10.1002/14651858.CD002768
Gruet M, Reychler G, Radtke T. Aerobic exercise in adults with cystic fibrosis: A call for long-term trials. Eur Respir Rev. 2023;32(170):220186. doi:10.1183/16000617.0186-2022
Ward N, Stiller K, Holland AE. Treadmill exercise improves mucociliary clearance and ease of expectoration in cystic fibrosis patients. Thorax. 2021;76(8):763–765. doi:10.1136/thoraxjnl-2021-217662
Dwyer TJ, Elkins MR, Bye PT. The role of resistance training in cystic fibrosis: A systematic review. J Cyst Fibros. 2021;20(3):495–505. doi:10.1016/j.jcf.2020.12.010
Burtin C, Van Remoortel H, Vrijsen B, Gosselink R, Langer D, Proesmans M, et al. Impact of resistance training combined with neuromuscular electrical stimulation in cystic fibrosis: A pilot trial. Respir Med. 2022;191:106716. doi:10.1016/j.rmed.2021.106716
Radtke T, Stevens D, Benden C, Hebestreit H, Kriemler S. The relationship between exercise capacity, muscle strength and lung function in cystic fibrosis: A systematic review. Healthcare (Basel). 2022;10(11):2205. doi:10.3390/healthcare10112205
Lima JDA, Ribeiro-Samora GA, Ferreira JBD, Lima VP, Coelho CC, Macedo J, et al. Endurance, resistance and combined training on cardiorespiratory fitness and muscle strength in cystic fibrosis: A randomized controlled trial. J Cyst Fibros. 2023;22(3):510–517. doi:10.1016/j.jcf.2022.07.012
Dwyer TJ, Rautela L, Elkins MR. Adherence benefits of combined training in cystic fibrosis: A pilot trial. BMJ Open Sport Exerc Med. 2023;9(1):e001529. doi:10.1136/bmjsem-2022-001529
Sawyer A, Clancy O, Fothergill H, et al. Inspiratory muscle training in cystic fibrosis: A systematic review and meta-analysis. J Cyst Fibros. 2021;20(6):1005–1014. doi:10.1016/j.jcf.2021.05.004
Kaeotawee P, Boonpheng B, Jantarapong Y, Wongchalee W, Keawutan P. Effect of inspiratory muscle training on respiratory muscle strength and functional capacity in children and adolescents with cystic fibrosis: A randomized controlled trial. Front Pediatr. 2022;10:942076. doi:10.3389/fped.2022.942076
Moran F, Bradley JM, Piper AJ. Combined IMT and exercise training in cystic fibrosis: A randomised controlled trial. Thorax. 2022;77(9):895–902. doi:10.1136/thoraxjnl-2021-217743
Poulsen M, Holland AE, Button B, Jones AW, et al. Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis: A qualitative study. Pediatr Pulmonol. 2024;59(5):1217–1226. doi:10.1002/ppul.26889
Pessoa E, Ferreira M, Baixinho CL. Telerehabilitation in Children and Adolescents with Cystic Fibrosis: A Scoping Review. Healthcare (Basel). 2024;12(10):971. doi:10.3390/healthcare12100971
Qin Y, Hamana K, Gale NS. Remote exercise services for people with cystic fibrosis: experiences and perceptions from people with cystic fibrosis and members of cystic fibrosis multidisciplinary teams. Disabil Rehabil. 2024. doi:10.1080/09638288.2024.2420832
Radtke T, Hulzebos EHJ, Schneiderman JE, et al. Physical activity interventions for ≥ 6 months probably improve exercise capacity versus usual care in people with cystic fibrosis: a Cochrane systematic review. Cochrane Database Syst Rev. 2022;(8):CD002768. doi:10.1002/14651858.CD002768
Ladune R, Filleul V, Falzon C, et al. Perceptions of barriers to and facilitators of physical activity in adults with cystic fibrosis. Physiother Theory Pract. 2023;39(1):117–127. doi:10.1080/09593985.2021.2005201
Smith TP, et al. Pulmonary exacerbations and their impact on exercise participation in individuals with cystic fibrosis: A longitudinal observational study. Thorax. 2024;79(2):155–162. doi:10.1136/thorax-2023-220118
Saynor ZL, Gruet M, McNarry MA, Button B, Morrison L, Wagner M, Sawyer A, Hebestreit H, Radtke T, Urquhart DS; European Cystic Fibrosis Society Exercise Working Group. Guidance and standard operating procedures for functional exercise testing in cystic fibrosis. Eur Respir Rev. 2023;32(169):230029. doi:10.1183/16000617.0029-2023
Hurley N, Moyna NM, Kehoe B, McCaffrey N, Redmond K, Hardcastle SJ. Factors influencing physical activity in adults with cystic fibrosis. BMC Pulm Med. 2021;21(1):113. doi:10.1186/s12890-021-01482-x.
Philipsen LKD, Barker AR, Williams CA, et al. Changes in exercise capacity in people with cystic fibrosis following interventions. J Cyst Fibros. 2024;23(4):621–9. doi:10.1016/j.jcf.2024.01.010
Denford S, et al. Social support and exercise engagement in cystic fibrosis: A mixed-methods study. BMC Pulm Med. 2023;23:144. doi:10.1186/s12890-023-02314-y
Hebestreit H, et al. Positive exercise experiences and intrinsic motivation in cystic fibrosis: Implications for long-term participation. Eur Respir Rev. 2025;34(175):230190. doi:10.1183/16000617.0190-2023
Hebestreit H, Hulzebos EH, Schneiderman JE, et al. Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis. J Cyst Fibros. 2022;21(2):265-273. doi:10.1016/j.jcf.2021.08.011
Radtke T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev. 2022;11:CD002768. doi:10.1002/14651858.CD002768.pub6
Saynor ZL, Barker AR, Oades PJ, Williams CA. Exercise testing and prescription in cystic fibrosis. Expert Rev Respir Med. 2023;17(2):161-173. doi:10.1080/17476348.2022.2136107
Hebestreit H, Radtke T, Kriemler S, et al. Exercise prescription and training in cystic fibrosis: from evidence to practice. Eur Respir Rev. 2023;32(169):230022. doi:10.1183/16000617.0022-2023
Kaltsakas G, Barker AR, Oades PJ, Williams CA. Interval versus constant-load exercise training in adults with cystic fibrosis: effects on oxygen desaturation and breathlessness. Eur Respir J. 2021;58(2):2000165. doi:10.1183/13993003.00165-2020
Taylor-Cousar JL, Jain R, Barto TL, et al. Sweat electrolyte losses during exercise in cystic fibrosis: implications for fluid and salt replacement. J Appl Physiol. 2021;130(2):478-486. doi:10.1152/japplphysiol.00513.2020
Zemanick ET, Taylor-Cousar JL. Hemoptysis in cystic fibrosis: pathophysiology, management, and prevention strategies. Clin Chest Med. 2021;42(4):651-666. doi:10.1016/j.ccm.2021.08.004
Saynor ZL, Barker AR, Oades PJ, Williams CA. Exercise testing and prescription in cystic fibrosis. Expert Rev Respir Med. 2023;17(2):161-173. doi:10.1080/17476348.2022.2136107
Hurley N, Kehoe B, McCaffrey N, Redmond K, Cullen L, Moyna NM. Recommendations to improve physical activity prescription for the cystic fibrosis population: an Irish perspective. BMC Health Serv Res. 2020 Nov 19;20(1):1052. doi:10.1186/s12913-020-05910-2
Ferreira A, et al. Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: Randomized controlled trial. Scand J Med Sci Sports. 2024 Jan;34(1):e14564. doi: 10.1111/sms.14564
Radtke T, Smith S, Nevitt SJ, Hebestreit H, Kriemler S. Effectiveness of physical exercise interventions on pulmonary function and physical fitness in children and adults with cystic fibrosis: a systematic review with meta-analysis. Clin Rehabil. 2022;36(12):1438–1454.
European Cystic Fibrosis Society Exercise Working Group. Guidance and standard operating procedures for functional exercise testing in cystic fibrosis. Eur Respir Rev. 2023;32(169):230029. doi:10.1183/16000617.0029-2023.
Cox NS, et al. Physical activity and exercise training in cystic fibrosis. Cochrane Database Syst Rev. 2022 Nov;(11):CD002768.
Morrison A, et al. Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis. J Cyst Fibros. 2024; (Epub ahead of print). doi:10.1002/ppul.26889.
Views:
72
Downloads:
16
Copyright (c) 2025 Weronika Worosz, Diana Wisz, Filip Maciej Huzarski, Katarzyna Adrianna Tryniecka, Katarzyna Maria Turek, Alicja Zań
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
